Michael B Hoffman bought $70k of ANVS
director at Annovis Bio, Inc.. 20,000 shares at an average of $3.50, traded Nov 21, 2025, filed Nov 21, 2025.
Score components
- +15RoleDirector
- +8Trade size$70k at market
- -5Relative to holdingsUnder 1% of holdings (0.8%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.7%, 3m -34.6%, 6m -41.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-115090, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2025 | POpen-market purchase Common Stock | +10,000 | $3.49 | $35k | 2,480,539 | Nov 21, 2025 |
| Nov 21, 2025 | POpen-market purchase Common Stock | +10,000 | $3.50 | $35k | 2,490,539 | Nov 21, 2025 |
Related signals
Other insiders at Annovis Bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $143k 76,344 shares | +2% | |
| 54Moderate | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $1.5M 713,800 shares | +28% | |
| 32Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $194k 45,000 shares | +2% | |
| 31Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $160k 39,200 shares | +2% | |
| 31Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $160k 39,200 shares | +2% | |
| 20Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $32k 15,000 shares | +1% | |
| 58Moderate | Annovis Bio, Inc. | Michael B Hoffman director | $2.0M 975,610 shares | +66% | |
| 48Moderate | Annovis Bio, Inc. | Maria-Luisa Maccecchini President & CEO | $200k 97,561 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.